Knockdown of both PTBP1 and PTBP2 slowed glioma cell proliferation [36], and PTBP2 null mice died shortly after birth and exhibited misregulation of alternative splicing in genes involved in cytoskeletal remodeling and cell proliferation [37, 38]. Here, PTBP2 is linked to central nervous system cancer.